Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ZYNEX INC Director's Dealing 2021

Feb 3, 2021

34599_dirs_2021-02-03_8ed9f531-788c-4895-b7d4-4bcbde3ca39f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ZYNEX INC (ZYXI)
CIK: 0000846475
Period of Report: 2021-01-27

Reporting Person: Lucsok Anna (See Remarks)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (Right to buy) $2.63 2028-08-17 Common stock (1000) Direct
Employee Stock Option (Right to buy) $3.44 2028-11-06 Common stock (1000) Direct
Employee Stock Option (Right to buy) $3.95 2029-02-07 Common stock (1000) Direct
Employee Stock Option (Right to buy) $8.94 2029-09-16 Common stock (5000) Direct

Footnotes

F1: On August 17, 2018, Zynex, Inc. (the "Issuer") issued to Ms. Anna Lucsok (the "Reporting Person") options to purchase 1,000 shares of the Company's common stock at an exercise price of $2.63 per share. The issuance was made pursuant to the Issuer's 2017 Stock Incentive Plan. The options vest in four equal annual installments commencing on August 17, 2019.

F2: On November 6, 2018, the Issuer issued to the Reporting Person options to purchase 1,000 shares of the Company's common stock at an exercise price of $3.44 per share. The issuance was made pursuant to the Issuer's 2017 Stock Incentive Plan. The options vest in four equal annual installments commencing on November 6, 2019.

F3: On February 7, 2019, the Issuer issued to the Reporting Person options to purchase 1,000 shares of the Company's common stock at an exercise price of $3.95 per share. The issuance was made pursuant to the Issuer's 2017 Stock Incentive Plan. The options vest in four equal annual installments commencing on February 7, 2020.

F4: On September 16, 2019, the Issuer issued to the Reporting Person options to purchase 5,000 shares of the Company's common stock at an exercise price of $8.94 per share. The issuance was made pursuant to the Issuer's 2017 Stock Incentive Plan. The options vest in four equal annual installments commencing on September 16, 2020.